ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0668

Differential Expression of Interferon Related Genes in SLE Patients of Asian and European Ancestries Abstract

Ian Rector1, Prathyusha Bachali2, Jinoos Yazdany3, Maria Dall'Era4, Amrie Grammer5 and Peter lipsky1, 1AMPEL Biosolutions, Charlottesville, VA, 2AMPEL BioSolutions, Redmond, WA, 3UCSF, San Francisco, CA, 4University of California, Division of Rheumatology, San Francisco, CA, 5AMPEL LLC, Charlottesville, VA

Meeting: ACR Convergence 2022

Keywords: Autoantibody(ies), Bioinformatics, interferon, race/ethnicity, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2022

Title: SLE – Etiology and Pathogenesis Poster

Session Type: Poster Session B

Session Time: 9:00AM-10:30AM

Background/Purpose: Interferon has been shown to play a role in the pathogenesis of SLE, but insufficient studies have been conducted into the differences in interferon response between patients of different ancestries. African ancestry patients have been shown to have greater interferon response than European ancestry (EA) patients related to the involvement of autoantibodies, but the differences between Asian ancestry (AsA) patients and EA patients are not well studied. This question was explored using a bulk RNA-Seq analysis from the CLUES (California Lupus Epidemiology Study) of both AsA and EA patients in four cell types: CD14 monocytes, CD19 B cells, CD4 T cells and NK cells.

Methods: We employed GSVA, or Gene Set Variability Analysis, a statistical method that focuses on enrichment of sets of genes rather than individual genes to examine the differences in IFN expression between the two ancestral groups. We initially used seven different interferon response signatures (IGS) encompassing the response to all Type 1 IFN (IFN Core), IFNA2, IFNB1, IFNW1 and IFNG as well as IL12 and TNF as controls. The Singscore R package was used to rank the genes of each of the seven IFN modules by expression, and create a more concise version of the IFN Core signature and the IFNA2 signature.

Results: AsA patients exhibited higher levels of IFN core and IFNA2 IGS than EA patients in all four cell types. GSVA was used to examine how the presence of different autoantibodies (anti-DNA, anti-RNP, anti-SSA, anti-Sm) was associated with the IGS. Patients who had autoantibodies tended to have higher IFN signatures, but not IL12 and TNF signatures, compared to patients who lacked autoantibodies. EA patients who lacked autoantibodies were generally IGS negative. In both AsA and EA SLE patients the IGS was significantly greater in subjects with anti-RNP autoantibodies.

Conclusion: These results show that AsA SLE patients have higher IGS than EA patients and this is manifest in all cell types. Moreover, the presence of the IGS is greatest is patients with anti-RNP autoantibodies, and especially in SLE patients of AsA. These results link the presence of the IGS to anti-RNP autoantibodies in AsA patients with SLE.

Supporting image 1

Figure 1: The IGS is more frequent in SLE patients of Asian ancestry (top) and in those with anti-RNP autoantibodies (bottom). Both plots are for the monocyte cell population.


Disclosures: I. Rector, None; P. Bachali, None; J. Yazdany, AstraZeneca, Gilead, Bristol-Myers Squibb(BMS), Aurinia, Astra Zeneca, Pfizer; M. Dall'Era, GlaxoSmithKline (GSK), AstraZeneca, Aurinia, BMS, Amgen; A. Grammer, None; P. lipsky, None.

To cite this abstract in AMA style:

Rector I, Bachali P, Yazdany J, Dall'Era M, Grammer A, lipsky P. Differential Expression of Interferon Related Genes in SLE Patients of Asian and European Ancestries Abstract [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/differential-expression-of-interferon-related-genes-in-sle-patients-of-asian-and-european-ancestries-abstract/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/differential-expression-of-interferon-related-genes-in-sle-patients-of-asian-and-european-ancestries-abstract/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology